1. Schorr S, Legum C, Ochshorn M. Spondyloenchondrodysplasia. Enchondromatomosis with severe platyspondyly in two brothers. Radiology. 1976; 118:133–139.
2. Frydman M, Bar-Ziv J, Preminger-Shapiro R, Brezner A, Brand N, Ben-Ami T, et al. Possible heterogeneity in spondyloenchondrodysplasia: quadriparesis, basal ganglia calcifications, and chondrocyte inclusions. Am J Med Genet. 1990; 36:279–284.
Article
3. Briggs TA, Rice GI, Adib N, Ades L, Barete S, Baskar K, et al. Spondyloenchondrodysplasia due to mutations in ACP5: a comprehensive survey. J Clin Immunol. 2016; 36:220–234.
Article
4. Renella R, Schaefer E, LeMerrer M, Alanay Y, Kandemir N, Eich G, et al. Spondyloenchondrodysplasia with spasticity, cerebral calcifications, and immune dysregulation: clinical and radiographic delineation of a pleiotropic disorder. Am J Med Genet A. 2006; 140:541–550.
Article
5. Bae JS, Kim NK, Lee C, Kim SC, Lee HR, Song HR, et al. Comprehensive genetic exploration of skeletal dysplasia using targeted exome sequencing. Genet Med. 2016; 18:563–569.
Article
6. Navarro V, Scott C, Briggs TA, Barete S, Frances C, Lebon P, et al. Two further cases of spondyloenchondrodysplasia (SPENCD) with immune dysregulation. Am J Med Genet A. 2008; 146A:2810–2815.
Article
7. Wang R, Xu Y, Lv R, Chen J. Systemic lupus erythematosus associated with Moyamoya syndrome: a case report and literature review. Lupus. 2013; 22:629–633.
Article
8. Jeong HC, Kim YJ, Yoon W, Joo SP, Lee SS, Park YW. Moyamoya syndrome associated with systemic lupus erythematosus. Lupus. 2008; 17:679–682.
Article